This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nelson, A. E. Articles by Ho, K. K. Search for Related Content PubMed PubMed Citation Articles by Nelson, A. E. Articles by Ho, K. K. Pubmed/NCBI databases Substance via MeSH Related Collections Neuroendocrinology and Pituitary Metabolism

Influence of Demographic Factors and Sport Type on Growth Hormone-Responsive Markers in Elite Athletes

Garvan Institute of Medical Research and Department of Endocrinology (A.E.N., T.V.N., K.-C.L., K.K.H.), Darlinghurst, New South Wales 2010, Australia; Australian Sports Drug Testing Laboratory (C.J.H., G.J.T., R.K.), National Measurement Institute, Pymble, New South Wales 2073, Australia; ANZAC Research Institute (M.J.S., D.J.H.), Concord Hospital, University of Sydney, Sydney, New South Wales 2139, Australia; and Kolling Institute of Medical Research (R.C.B.), University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales 2065, Australia

Address all correspondence and requests for reprints to: Professor K. K. Ho, Pituitary Research Unit, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst 2010, Australia. E-mail: K.Ho{at}garvan.org.au.

Context: GH-responsive markers of the IGF system and of collagen turnover hold promise as the basis of a GH doping test.

Objective: The purpose of this study was to determine the influence of age, gender, body mass index (BMI), ethnicity, and sporting type on GH-responsive serum markers in a large cohort of elite athletes from different ethnic backgrounds.

Design: The study was designed as a cross-sectional study.

Participants: A total of 1103 elite athletes (699 males, 404 females), aged 22.2 ± 5.2 yr, from 12 countries and 10 major sporting categories participated in this study.

Main Outcome Measures: Serum IGF-I, IGF binding protein-3 (IGFBP-3), acid labile subunit (ALS), and collagen markers [N-terminal propeptide of type I procollagen (PINP), C-terminal telopeptide of type I collagen (ICTP), N-terminal propeptide of type III procollagen (PIIINP)] were measured.

Results: There was a significant negative correlation (r = –0.14 to –0.58, P < 0.0005) between age and each of the GH-responsive markers. Serum IGF-I, IGFBP-3, and ALS were all lower (P < 0.05), whereas the collagen markers PINP, ICTP, and PIIINP were higher (P < 0.05) in men than in women. Multiple regression analysis indicated that age, gender, BMI, and ethnicity accounted for 23–54% of total between-subject variability of the markers. Age and gender cumulatively accounted for 91% of the attributable variation of IGF-I and more than 80% for PINP, ICTP, and PIIINP. Gender exerted the greatest effect on ALS (48%), and BMI accounted for less than 12% attributable variation for all markers. The influence of ethnicity was greatest for IGFBP-3 and ALS; however, for the other markers, it accounted for less than 6% attributable variation. Analysis of 995 athletes indicated that sporting type contributed 5–19% of attributable variation.

Conclusions: Age and gender were major determinants of variability of GH-responsive markers except for IGFBP-3 and ALS. Ethnicity is unlikely to confound the validity of a GH doping test based on IGF-I and these collagen markers.

This article has been cited by other articles:

				S. Bhasin, E. J. He, M. Kawakubo, E. T. Schroeder, K. Yarasheski, G. J. Opiteck, A. Reicin, F. Chen, R. Lam, J. A. Tsou, et al. N-Terminal Propeptide of Type III Procollagen as a Biomarker of Anabolic Response to Recombinant Human GH and Testosterone J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4224 - 4233. [Abstract] [Full Text] [PDF]

				L. Di Luigi, A. E Rigamonti, F. Agosti, M. Mencarelli, P. Sgro, N. Marazzi, S. G Cella, E. E Muller, and A. Sartorio Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes Eur. J. Endocrinol., May 1, 2009; 160(5): 753 - 758. [Abstract] [Full Text] [PDF]

				M. Bidlingmaier, J. Suhr, A. Ernst, Z. Wu, A. Keller, C. J. Strasburger, and A. Bergmann High-Sensitivity Chemiluminescence Immunoassays for Detection of Growth Hormone Doping in Sports Clin. Chem., March 1, 2009; 55(3): 445 - 453. [Abstract] [Full Text] [PDF]

				T. V. Nguyen, A. E. Nelson, C. J. Howe, M. J. Seibel, R. C. Baxter, D. J. Handelsman, R. Kazlauskas, and K. K. Ho Within-Subject Variability and Analytic Imprecision of Insulinlike Growth Factor Axis and Collagen Markers: Implications for Clinical Diagnosis and Doping Tests Clin. Chem., August 1, 2008; 54(8): 1268 - 1276. [Abstract] [Full Text] [PDF]

				A. E. Nelson, U. Meinhardt, J. L. Hansen, I. H. Walker, G. Stone, C. J. Howe, K.-c. Leung, M. J. Seibel, R. C. Baxter, D. J. Handelsman, et al. Pharmacodynamics of Growth Hormone Abuse Biomarkers and the Influence of Gender and Testosterone: A Randomized Double-Blind Placebo-Controlled Study in Young Recreational Athletes J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2213 - 2222. [Abstract] [Full Text] [PDF]

				S. Melmed Update in Pituitary Disease J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 331 - 338. [Abstract] [Full Text] [PDF]

				J. Leger, I. Mercat, C. Alberti, D. Chevenne, P. Armoogum, J. Tichet, and P. Czernichow The relationship between the GH/IGF-I axis and serum markers of bone turnover metabolism in healthy children Eur. J. Endocrinol., November 1, 2007; 157(5): 685 - 692. [Abstract] [Full Text] [PDF]